(Q38313275)

2 September 2017

title

Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis (English)

1 reference

2 September 2017

1 reference

5

Damian C Crowther

1 reference

2 September 2017

Lynda K Sharp

1

1 reference

2 September 2017

Meera Mallya

2

1 reference

2 September 2017

Kerri J Kinghorn

3

1 reference

2 September 2017

Zhen Wang

4

1 reference

2 September 2017

James A Huntington

6

1 reference

2 September 2017

Didier Belorgey

7

1 reference

2 September 2017

David A Lomas

8

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

2 September 2017

number of pages

13

1 reference

inferred from page(s)

published in

FEBS Journal

1 reference

2 September 2017

volume

273

1 reference

2 September 2017

issue

11

1 reference

2 September 2017

page(s)

2540-2552

1 reference

Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05262.X

Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05262.X

Familial encephalopathy with neuroserpin inclusion bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05262.X

Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05262.X

Studies of the development of brain barrier systems to lipid insoluble molecules in fetal sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05262.X

Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05262.X

10.1111/J.1742-4658.2006.05262.X

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3qgehc3e7vdepavrwqhd6xcox4

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_3qgehc3e7vdepavrwqhd6xcox4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3qgehc3e7vdepavrwqhd6xcox4

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/3qgehc3e7vdepavrwqhd6xcox4

1 reference

30 July 2022